81qd, an innovative, analytics-driven healthcare solutions partner, provides life sciences companies with customized, high-value and efficient solutions designed to maximize their brands’ commercial potential through all stages of the product life cycle from clinical development through the loss of exclusivity.
Our multidisciplinary team of data scientists, medical strategists and marketing professionals have decades of experience in healthcare analytics.
81qd is differentiated by our ability to provide end-to-end solutions, from strategic planning to tactical execution. We are at the forefront of the latest advances in data science, which power our proprietary solutions to solve our clients’ business challenges.
Services and Offerings
Actionable, AI-driven analytics fueled by real-world data. Plexus, our machine learning-based solution, identifies the true clinical influencers — those individuals who impact the care of patients far beyond their own practice by influencing the behavior of other clinicians. This provides our clients the competitive advantage of being able to leverage
the most influential clinicians in a specific disease state to drive the diffusion of innovation through influence-based marketing.
Orion, our patient-finding solution, utilizes predictive analytics to identify specific clinicians currently managing yet-to-be-diagnosed patients with diseases that are difficult to diagnose. This proprietary solution leverages machine learning and computational statistics to analyze disparate sources of data — including healthcare encounter data, laboratory data and electronic health records to reliably predict which patients have the highest probability of having a particular difficult-to-diagnose disease.
Acuity, our global stakeholder management platform, employs industry-leading methodologies for data mining, cleansing and disambiguation to identify and profile clinicians.
Our analyses are derived from disparate sources of data that are carefully curated to meet the specific needs of individual clients. As our clients continue to build a wealth of data on thought leaders, we provide them with customized dashboards to identify, measure and track thought leader engagements.
What are the game-changing ideas that didn’t come to pass in 2019 that will prove transformative in 2020?
“We expect the application of AI to real-world data to make a transformational impact in 2020. AI-driven algorithms can help identify undiagnosed patients with difficult-to-diagnose conditions and their HCPs. The full potential of AI to accelerate diagnosis will be more impactful in 2020 as BioPharma takes a leap forward by considering: how to engage HCPs and patients without alienating them and when and where to engage HCPs and patients.” — Robert Gabruk, Managing director
Address: 750 Third Avenue, Suite 1003, New York, NY 10017
Phone: 212-661-7685 Website: www.81qd.com
Year Founded: 2006
Holding Company: Independent
Sample Clients: Small to large biopharmaceutical companies
New Business Contact: Robert Gabruk, managing director, 646-416-5653, [email protected]
From the March 02, 2020 Issue of MM+M - Medical Marketing and Media